<corpus id="HPRD50">
  <document id="HPRD50.d6" origId="10925297">
    <sentence id="HPRD50.d6.s0" origId="10925297.1.1" text="Regulation of neutrophil adhesion by pituitary growth hormone accompanies tyrosine phosphorylation of ____, p125FAK, and ________">
      <entity charOffset="102-105" id="HPRD50.d6.s0.e0" origId="13" type="pm0110818" />
      <entity charOffset="121-128" id="HPRD50.d6.s0.e1" origId="18" type="pm0119378" />
      <pair e1="HPRD50.d6.s0.e0" e2="HPRD50.d6.s0.e1" id="HPRD50.d6.s0.p0" />
    </sentence>
    <sentence id="HPRD50.d6.s1" origId="10925297.2.10" text="These results suggest that pituitary GH modulates neutrophil adhesion through tyrosine phosphorylation of ____, p125FAK, and ________ and actin polymerization">
      <entity charOffset="106-109" id="HPRD50.d6.s1.e0" origId="14" type="pm0110818" />
      <entity charOffset="125-132" id="HPRD50.d6.s1.e1" origId="19" type="pm0119378" />
      <pair e1="HPRD50.d6.s1.e0" e2="HPRD50.d6.s1.e1" id="HPRD50.d6.s1.p0" />
    </sentence>
    <sentence id="HPRD50.d6.s2" origId="10925297.2.4" text="Pituitary GH triggered the tyrosine phosphorylation of ______________ (____) and _____ in neutrophils">
      <entity charOffset="55-68" id="HPRD50.d6.s2.e0" origId="10" type="pm0110818" />
      <entity charOffset="71-74" id="HPRD50.d6.s2.e1" origId="12" type="pm0110818" />
      <entity charOffset="81-85" id="HPRD50.d6.s2.e2" origId="15" type="pm0118656" />
      <pair e1="HPRD50.d6.s2.e0" e2="HPRD50.d6.s2.e1" id="HPRD50.d6.s2.p0" />
      <pair e1="HPRD50.d6.s2.e0" e2="HPRD50.d6.s2.e2" id="HPRD50.d6.s2.p1" />
      <pair e1="HPRD50.d6.s2.e1" e2="HPRD50.d6.s2.e2" id="HPRD50.d6.s2.p2" />
    </sentence>
    <sentence id="HPRD50.d6.s3" origId="10925297.2.6" text="Preincubation with genistein, a tyrosine kinase inhibitor, blocked the GH-stimulated adhesion and ____, _____, p125FAK, and ________ phosphorylation">
      <entity charOffset="98-101" id="HPRD50.d6.s3.e0" origId="15" type="pm0110818" />
      <entity charOffset="104-108" id="HPRD50.d6.s3.e1" origId="17" type="pm0118656" />
      <entity charOffset="124-131" id="HPRD50.d6.s3.e2" origId="22" type="pm0119378" />
      <pair e1="HPRD50.d6.s3.e0" e2="HPRD50.d6.s3.e1" id="HPRD50.d6.s3.p0" />
      <pair e1="HPRD50.d6.s3.e0" e2="HPRD50.d6.s3.e2" id="HPRD50.d6.s3.p1" />
      <pair e1="HPRD50.d6.s3.e1" e2="HPRD50.d6.s3.e2" id="HPRD50.d6.s3.p2" />
    </sentence>
    <sentence id="HPRD50.d6.s4" origId="10925297.2.8" text="Immunoprecipitation experiments revealed a physical association of ____ with p125FAK via _____ in vivo">
      <entity charOffset="67-70" id="HPRD50.d6.s4.e0" origId="8" type="pm0110818" />
      <entity charOffset="89-93" id="HPRD50.d6.s4.e1" origId="12" type="pm0118656" />
      <pair e1="HPRD50.d6.s4.e0" e2="HPRD50.d6.s4.e1" id="HPRD50.d6.s4.p0" />
    </sentence>
  </document>
  <document id="HPRD50.d10" origId="11238599">
    <sentence id="HPRD50.d10.s0" origId="11238599.1.1" text="Cutting edge: ____ functions as a T cell counterreceptor for the macrophage adhesion receptor ____________ (________)">
      <entity charOffset="14-17" id="HPRD50.d10.s0.e0" origId="4" type="pm0122945" />
      <entity charOffset="94-105" id="HPRD50.d10.s0.e1" origId="16" type="pm0108007" />
      <entity charOffset="108-115" id="HPRD50.d10.s0.e2" origId="18" type="pm0108007" />
      <pair e1="HPRD50.d10.s0.e0" e2="HPRD50.d10.s0.e1" id="HPRD50.d10.s0.p0" />
      <pair e1="HPRD50.d10.s0.e0" e2="HPRD50.d10.s0.e2" id="HPRD50.d10.s0.p1" />
      <pair e1="HPRD50.d10.s0.e1" e2="HPRD50.d10.s0.e2" id="HPRD50.d10.s0.p2" />
    </sentence>
    <sentence id="HPRD50.d10.s1" origId="11238599.2.5" text="The 130- and 240-kDa sialoadhesin-binding glycoproteins were identified as the sialomucins ____ and ________________________________ (_____), respectively">
      <entity charOffset="91-94" id="HPRD50.d10.s1.e0" origId="12" type="pm0122945" />
      <entity charOffset="100-131" id="HPRD50.d10.s1.e1" origId="17" type="pm0119091" />
      <entity charOffset="134-138" id="HPRD50.d10.s1.e2" origId="19" type="pm0119091" />
      <pair e1="HPRD50.d10.s1.e0" e2="HPRD50.d10.s1.e1" id="HPRD50.d10.s1.p0" />
      <pair e1="HPRD50.d10.s1.e0" e2="HPRD50.d10.s1.e2" id="HPRD50.d10.s1.p1" />
      <pair e1="HPRD50.d10.s1.e1" e2="HPRD50.d10.s1.e2" id="HPRD50.d10.s1.p2" />
    </sentence>
    <sentence id="HPRD50.d10.s2" origId="11238599.2.6" text="____ expressed in COS cells supported increased binding to immobilized ____________">
      <entity charOffset="0-3" id="HPRD50.d10.s2.e0" origId="1" type="pm0122945" />
      <entity charOffset="71-82" id="HPRD50.d10.s2.e1" origId="11" type="pm0108007" />
      <pair e1="HPRD50.d10.s2.e0" e2="HPRD50.d10.s2.e1" id="HPRD50.d10.s2.p0" />
    </sentence>
    <sentence id="HPRD50.d10.s3" origId="11238599.2.7" text="Finally, ____________ bound different glycoforms of ____ expressed in Chinese hamster ovary cells, including unbranched (core 1) and branched (core 2) O:-linked glycans, that are normally found on ____ in resting and activated T cells, respectively">
      <entity charOffset="9-20" id="HPRD50.d10.s3.e0" origId="3" type="pm0108007" />
      <entity charOffset="52-55" id="HPRD50.d10.s3.e1" origId="8" type="pm0122945" />
      <entity charOffset="197-200" id="HPRD50.d10.s3.e2" origId="38" type="pm0122945" />
      <pair e1="HPRD50.d10.s3.e0" e2="HPRD50.d10.s3.e1" id="HPRD50.d10.s3.p0" />
      <pair e1="HPRD50.d10.s3.e0" e2="HPRD50.d10.s3.e2" id="HPRD50.d10.s3.p1" />
      <pair e1="HPRD50.d10.s3.e1" e2="HPRD50.d10.s3.e2" id="HPRD50.d10.s3.p2" />
    </sentence>
    <sentence id="HPRD50.d10.s4" origId="11238599.2.8" text="These results identify ____ as a T cell counterreceptor for ____________ and suggest that in addition to its anti-adhesive role ____ may promote cell-cell interactions">
      <entity charOffset="23-26" id="HPRD50.d10.s4.e0" origId="4" type="pm0122945" />
      <entity charOffset="60-71" id="HPRD50.d10.s4.e1" origId="11" type="pm0108007" />
      <entity charOffset="128-131" id="HPRD50.d10.s4.e2" origId="21" type="pm0122945" />
      <pair e1="HPRD50.d10.s4.e0" e2="HPRD50.d10.s4.e1" id="HPRD50.d10.s4.p0" />
      <pair e1="HPRD50.d10.s4.e0" e2="HPRD50.d10.s4.e2" id="HPRD50.d10.s4.p1" />
      <pair e1="HPRD50.d10.s4.e1" e2="HPRD50.d10.s4.e2" id="HPRD50.d10.s4.p2" />
    </sentence>
  </document>
  <document id="HPRD50.d15" origId="12056825">
    <sentence id="HPRD50.d15.s0" origId="12056825.1.1" text="Physical association of _______________ with ______, a novel glycosylphosphatidylinositol-anchored protein with potential for regulating adhesion and migration">
      <entity charOffset="24-38" id="HPRD50.d15.s0.e0" origId="6" type="pm0114514" />
      <entity charOffset="45-50" id="HPRD50.d15.s0.e1" origId="8" type="pm0100260" />
      <pair e1="HPRD50.d15.s0.e0" e2="HPRD50.d15.s0.e1" id="HPRD50.d15.s0.p0" />
    </sentence>
    <sentence id="HPRD50.d15.s1" origId="12056825.2.2" text="To clarify the mechanisms by which ______ functions on leukocytes, we explored the possibility of its physical association with _______________ which is important for leukocyte adherence, locomotion, and extravasation">
      <entity charOffset="35-40" id="HPRD50.d15.s1.e0" origId="7" type="pm0100260" />
      <entity charOffset="128-142" id="HPRD50.d15.s1.e1" origId="23" type="pm0114514" />
      <pair e1="HPRD50.d15.s1.e0" e2="HPRD50.d15.s1.e1" id="HPRD50.d15.s1.p0" />
    </sentence>
    <sentence id="HPRD50.d15.s2" origId="12056825.2.3" text="_______________, detected by anti-CD18 mAb, was coprecipitated with ______ from human neutrophil lysates by a mAb to ______">
      <entity charOffset="0-14" id="HPRD50.d15.s2.e0" origId="3" type="pm0114514" />
      <entity charOffset="68-73" id="HPRD50.d15.s2.e1" origId="13" type="pm0100260" />
      <entity charOffset="117-122" id="HPRD50.d15.s2.e2" origId="22" type="pm0100260" />
      <pair e1="HPRD50.d15.s2.e0" e2="HPRD50.d15.s2.e1" id="HPRD50.d15.s2.p0" />
      <pair e1="HPRD50.d15.s2.e0" e2="HPRD50.d15.s2.e2" id="HPRD50.d15.s2.p1" />
      <pair e1="HPRD50.d15.s2.e1" e2="HPRD50.d15.s2.e2" id="HPRD50.d15.s2.p2" />
    </sentence>
    <sentence id="HPRD50.d15.s3" origId="12056825.2.4" text="In addition, ______ was immunoprecipitated from human neutrophil lysates by anti-human ____ mAb">
      <entity charOffset="13-18" id="HPRD50.d15.s3.e0" origId="4" type="pm0100260" />
      <entity charOffset="87-90" id="HPRD50.d15.s3.e1" origId="13" type="pm0105418||pm0114514" />
      <pair e1="HPRD50.d15.s3.e0" e2="HPRD50.d15.s3.e1" id="HPRD50.d15.s3.p0" />
    </sentence>
    <sentence id="HPRD50.d15.s4" origId="12056825.2.5" text="These results clearly show that ______ is physically associated with _______________ in human neutrophils">
      <entity charOffset="32-37" id="HPRD50.d15.s4.e0" origId="6" type="pm0100260" />
      <entity charOffset="69-83" id="HPRD50.d15.s4.e1" origId="13" type="pm0114514" />
      <pair e1="HPRD50.d15.s4.e0" e2="HPRD50.d15.s4.e1" id="HPRD50.d15.s4.p0" />
    </sentence>
  </document>
  <document id="HPRD50.d17" origId="12200442">
    <sentence id="HPRD50.d17.s0" origId="12200442.2.2" text="________ (type II isozyme) contains a __________ homology domain at the N terminus and a sterile alpha motif domain at the C terminus">
      <entity charOffset="0-7" id="HPRD50.d17.s0.e0" origId="1" type="pm0126604" />
      <entity charOffset="38-47" id="HPRD50.d17.s0.e1" origId="9" type="pm0125262" />
      <pair e1="HPRD50.d17.s0.e0" e2="HPRD50.d17.s0.e1" id="HPRD50.d17.s0.p0" />
    </sentence>
  </document>
  <document id="HPRD50.d28" origId="14657349">
    <sentence id="HPRD50.d28.s0" origId="14657349.2.2" text="We report that ____ (MutS homolog 2) protein interacts with the ATR (ATM- and Rad3-related) kinase to form a signaling module and regulate the phosphorylation of ____ and ____ (structure maintenance of chromosome 1)">
      <entity charOffset="15-18" id="HPRD50.d28.s0.e0" origId="4" type="pm0121865" />
      <entity charOffset="162-165" id="HPRD50.d28.s0.e1" origId="31" type="pm0113524" />
      <entity charOffset="171-174" id="HPRD50.d28.s0.e2" origId="33" type="pm0116233" />
      <pair e1="HPRD50.d28.s0.e0" e2="HPRD50.d28.s0.e1" id="HPRD50.d28.s0.p0" />
      <pair e1="HPRD50.d28.s0.e0" e2="HPRD50.d28.s0.e2" id="HPRD50.d28.s0.p1" />
      <pair e1="HPRD50.d28.s0.e1" e2="HPRD50.d28.s0.e2" id="HPRD50.d28.s0.p2" />
    </sentence>
    <sentence id="HPRD50.d28.s1" origId="14657349.2.3" text="We found that phosphorylation of ____ by ATR also requires checkpoint proteins _____ and replication protein A">
      <entity charOffset="33-36" id="HPRD50.d28.s1.e0" origId="6" type="pm0113524" />
      <entity charOffset="79-83" id="HPRD50.d28.s1.e1" origId="13" type="pm0117336" />
      <pair e1="HPRD50.d28.s1.e0" e2="HPRD50.d28.s1.e1" id="HPRD50.d28.s1.p0" />
    </sentence>
    <sentence id="HPRD50.d28.s2" origId="14657349.2.4" text="In contrast, phosphorylation of ____ by ATR is independent of _____ and replication protein A, suggesting that the signaling pathway leading to ____ phosphorylation is distinct from that mediated by the checkpoint proteins">
      <entity charOffset="32-35" id="HPRD50.d28.s2.e0" origId="6" type="pm0116233" />
      <entity charOffset="62-66" id="HPRD50.d28.s2.e1" origId="12" type="pm0117336" />
      <entity charOffset="144-147" id="HPRD50.d28.s2.e2" origId="25" type="pm0116233" />
      <pair e1="HPRD50.d28.s2.e0" e2="HPRD50.d28.s2.e1" id="HPRD50.d28.s2.p0" />
      <pair e1="HPRD50.d28.s2.e0" e2="HPRD50.d28.s2.e2" id="HPRD50.d28.s2.p1" />
      <pair e1="HPRD50.d28.s2.e1" e2="HPRD50.d28.s2.e2" id="HPRD50.d28.s2.p2" />
    </sentence>
    <sentence id="HPRD50.d28.s3" origId="14657349.2.5" text="In addition, both ____ and _____ are required for the activation of the S-phase checkpoint to suppress DNA synthesis in response to MNNG, and phosphorylation of ____ is required for cellular survival">
      <entity charOffset="18-21" id="HPRD50.d28.s3.e0" origId="5" type="pm0121865" />
      <entity charOffset="27-31" id="HPRD50.d28.s3.e1" origId="7" type="pm0117336" />
      <entity charOffset="161-164" id="HPRD50.d28.s3.e2" origId="29" type="pm0116233" />
      <pair e1="HPRD50.d28.s3.e0" e2="HPRD50.d28.s3.e1" id="HPRD50.d28.s3.p0" />
      <pair e1="HPRD50.d28.s3.e0" e2="HPRD50.d28.s3.e2" id="HPRD50.d28.s3.p1" />
      <pair e1="HPRD50.d28.s3.e1" e2="HPRD50.d28.s3.e2" id="HPRD50.d28.s3.p2" />
    </sentence>
  </document>
  <document id="HPRD50.d36" origId="8627166">
    <sentence id="HPRD50.d36.s0" origId="8627166.1.1" text="____ associates with _______________________________, Syk, and phospholipase C-gamma(1) upon B cell activation">
      <entity charOffset="0-3" id="HPRD50.d36.s0.e0" origId="1" type="pm0119833" />
      <entity charOffset="21-51" id="HPRD50.d36.s0.e1" origId="7" type="pm0105676" />
      <pair e1="HPRD50.d36.s0.e0" e2="HPRD50.d36.s0.e1" id="HPRD50.d36.s0.p0" />
    </sentence>
    <sentence id="HPRD50.d36.s1" origId="8627166.2.10" text="These results suggest that tyrosyl-phosphorylated ____ may be a substrate for ______ regulates tyrosyl phosphorylation of ____">
      <entity charOffset="50-53" id="HPRD50.d36.s1.e0" origId="6" type="pm0119833" />
      <entity charOffset="78-83" id="HPRD50.d36.s1.e1" origId="12" type="pm0105676" />
      <entity charOffset="122-125" id="HPRD50.d36.s1.e2" origId="17" type="pm0119833" />
      <pair e1="HPRD50.d36.s1.e0" e2="HPRD50.d36.s1.e1" id="HPRD50.d36.s1.p0" />
      <pair e1="HPRD50.d36.s1.e0" e2="HPRD50.d36.s1.e2" id="HPRD50.d36.s1.p1" />
      <pair e1="HPRD50.d36.s1.e1" e2="HPRD50.d36.s1.e2" id="HPRD50.d36.s1.p2" />
    </sentence>
    <sentence id="HPRD50.d36.s2" origId="8627166.2.4" text="The association of ______ with ____ was mediated by the NH2-terminal Src homology 2 (SH2) domain of ______">
      <entity charOffset="19-24" id="HPRD50.d36.s2.e0" origId="4" type="pm0105676" />
      <entity charOffset="31-34" id="HPRD50.d36.s2.e1" origId="6" type="pm0119833" />
      <entity charOffset="100-105" id="HPRD50.d36.s2.e2" origId="20" type="pm0105676" />
      <pair e1="HPRD50.d36.s2.e0" e2="HPRD50.d36.s2.e1" id="HPRD50.d36.s2.p0" />
      <pair e1="HPRD50.d36.s2.e0" e2="HPRD50.d36.s2.e2" id="HPRD50.d36.s2.p1" />
      <pair e1="HPRD50.d36.s2.e1" e2="HPRD50.d36.s2.e2" id="HPRD50.d36.s2.p2" />
    </sentence>
    <sentence id="HPRD50.d36.s3" origId="8627166.2.5" text="Complexes of either ____/______/Syk/PLC-gamma(1) could be isolated from B cells stimulated by BCR engagement or a mixture of hydrogen peroxidase and sodium orthovanadate, respectively">
      <entity charOffset="20-23" id="HPRD50.d36.s3.e0" origId="4" type="pm0119833" />
      <entity charOffset="25-30" id="HPRD50.d36.s3.e1" origId="6" type="pm0105676" />
      <pair e1="HPRD50.d36.s3.e0" e2="HPRD50.d36.s3.e1" id="HPRD50.d36.s3.p0" />
    </sentence>
    <sentence id="HPRD50.d36.s4" origId="8627166.2.8" text="Transient expression of ____ and a null mutant of ______ (PTP-1CM) in COS cells resulted in an increase in tyrosyl phosphorylation of ____ and its interaction with PTP-1CM">
      <entity charOffset="24-27" id="HPRD50.d36.s4.e0" origId="4" type="pm0119833" />
      <entity charOffset="50-55" id="HPRD50.d36.s4.e1" origId="10" type="pm0105676" />
      <entity charOffset="134-137" id="HPRD50.d36.s4.e2" origId="25" type="pm0119833" />
      <pair e1="HPRD50.d36.s4.e0" e2="HPRD50.d36.s4.e1" id="HPRD50.d36.s4.p0" />
      <pair e1="HPRD50.d36.s4.e0" e2="HPRD50.d36.s4.e2" id="HPRD50.d36.s4.p1" />
      <pair e1="HPRD50.d36.s4.e1" e2="HPRD50.d36.s4.e2" id="HPRD50.d36.s4.p2" />
    </sentence>
    <sentence id="HPRD50.d36.s5" origId="8627166.2.9" text="By contrast, ____ was not tyrosyl phosphorylated or associated with PTP-1CM in the presence of wild-type ______">
      <entity charOffset="13-16" id="HPRD50.d36.s5.e0" origId="4" type="pm0119833" />
      <entity charOffset="105-110" id="HPRD50.d36.s5.e1" origId="18" type="pm0105676" />
      <pair e1="HPRD50.d36.s5.e0" e2="HPRD50.d36.s5.e1" id="HPRD50.d36.s5.p0" />
    </sentence>
  </document>
  <document id="HPRD50.d37" origId="8650542">
    <sentence id="HPRD50.d37.s0" origId="8650542.2.3" text="_____ dimers formed through self-association of the TATA-binding polypeptide (___) subunit and could be immunoprecipitated with antibodies to __________, the core subunit of _____">
      <entity charOffset="0-4" id="HPRD50.d37.s0.e0" origId="1" type="pm0109127" />
      <entity charOffset="78-80" id="HPRD50.d37.s0.e1" origId="11" type="pm0109127" />
      <entity charOffset="142-151" id="HPRD50.d37.s0.e2" origId="25" type="pm0108292" />
      <entity charOffset="174-178" id="HPRD50.d37.s0.e3" origId="31" type="pm0109127" />
      <pair e1="HPRD50.d37.s0.e0" e2="HPRD50.d37.s0.e1" id="HPRD50.d37.s0.p0" />
      <pair e1="HPRD50.d37.s0.e0" e2="HPRD50.d37.s0.e2" id="HPRD50.d37.s0.p1" />
      <pair e1="HPRD50.d37.s0.e0" e2="HPRD50.d37.s0.e3" id="HPRD50.d37.s0.p2" />
      <pair e1="HPRD50.d37.s0.e1" e2="HPRD50.d37.s0.e2" id="HPRD50.d37.s0.p3" />
      <pair e1="HPRD50.d37.s0.e1" e2="HPRD50.d37.s0.e3" id="HPRD50.d37.s0.p4" />
      <pair e1="HPRD50.d37.s0.e2" e2="HPRD50.d37.s0.e3" id="HPRD50.d37.s0.p5" />
    </sentence>
  </document>
  <document id="HPRD50.d41" origId="9765306">
    <sentence id="HPRD50.d41.s0" origId="9765306.2.4" text="We report here that PLZF, and a structurally similar transcriptional repressor, _____, can interact with a variety of corepressor proteins in addition to SMRT, including the mSin3A protein and (for PLZF) _____________________">
      <entity charOffset="80-84" id="HPRD50.d41.s0.e0" origId="14" type="pm0100563" />
      <entity charOffset="204-224" id="HPRD50.d41.s0.e1" origId="39" type="pm0119729" />
      <pair e1="HPRD50.d41.s0.e0" e2="HPRD50.d41.s0.e1" id="HPRD50.d41.s0.p0" />
    </sentence>
  </document>
  <document id="HPRD50.d42" origId="9812988">
    <sentence id="HPRD50.d42.s0" origId="9812988.2.2" text="Herein, we show that a distinct IkappaB protein ____ also interacts with RXR, as shown in the yeast two-hybrid tests and _________________________ pull-down assays">
      <entity charOffset="48-51" id="HPRD50.d42.s0.e0" origId="10" type="pm0126712" />
      <entity charOffset="121-145" id="HPRD50.d42.s0.e1" origId="25" type="pm0116848" />
      <pair e1="HPRD50.d42.s0.e0" e2="HPRD50.d42.s0.e1" id="HPRD50.d42.s0.p0" />
    </sentence>
    <sentence id="HPRD50.d42.s1" origId="9812988.2.4" text="In contrast to ___________, ____ did not interact with the AF2 domain of RXR">
      <entity charOffset="15-25" id="HPRD50.d42.s1.e0" origId="4" type="pm0122183" />
      <entity charOffset="28-31" id="HPRD50.d42.s1.e1" origId="6" type="pm0126712" />
      <pair e1="HPRD50.d42.s1.e0" e2="HPRD50.d42.s1.e1" id="HPRD50.d42.s1.p0" />
    </sentence>
    <sentence id="HPRD50.d42.s2" origId="9812988.2.5" text="____ specifically interacted with the general transcription factors _____, TBP, and _____ but not with TFIIEalpha in the ___ pull-down assays">
      <entity charOffset="0-3" id="HPRD50.d42.s2.e0" origId="1" type="pm0126712" />
      <entity charOffset="68-72" id="HPRD50.d42.s2.e1" origId="9" type="pm0112772" />
      <entity charOffset="84-88" id="HPRD50.d42.s2.e2" origId="14" type="pm0112153||pm0118250" />
      <entity charOffset="121-123" id="HPRD50.d42.s2.e3" origId="21" type="pm0116848" />
      <pair e1="HPRD50.d42.s2.e0" e2="HPRD50.d42.s2.e1" id="HPRD50.d42.s2.p0" />
      <pair e1="HPRD50.d42.s2.e0" e2="HPRD50.d42.s2.e2" id="HPRD50.d42.s2.p1" />
      <pair e1="HPRD50.d42.s2.e0" e2="HPRD50.d42.s2.e3" id="HPRD50.d42.s2.p2" />
      <pair e1="HPRD50.d42.s2.e1" e2="HPRD50.d42.s2.e2" id="HPRD50.d42.s2.p3" />
      <pair e1="HPRD50.d42.s2.e1" e2="HPRD50.d42.s2.e3" id="HPRD50.d42.s2.p4" />
      <pair e1="HPRD50.d42.s2.e2" e2="HPRD50.d42.s2.e3" id="HPRD50.d42.s2.p5" />
    </sentence>
    <sentence id="HPRD50.d42.s3" origId="9812988.2.6" text="TBP and _____, however, were not able to interact with ___________">
      <entity charOffset="8-12" id="HPRD50.d42.s3.e0" origId="3" type="pm0112153||pm0118250" />
      <entity charOffset="55-65" id="HPRD50.d42.s3.e1" origId="13" type="pm0122183" />
      <pair e1="HPRD50.d42.s3.e0" e2="HPRD50.d42.s3.e1" id="HPRD50.d42.s3.p0" />
    </sentence>
    <sentence id="HPRD50.d42.s4" origId="9812988.2.7" text="Accordingly, ____ coactivated the 9-cis-RA-induced transactivations of RXR, in contrast to the inhibitory actions of ___________">
      <entity charOffset="13-16" id="HPRD50.d42.s4.e0" origId="3" type="pm0126712" />
      <entity charOffset="117-127" id="HPRD50.d42.s4.e1" origId="18" type="pm0122183" />
      <pair e1="HPRD50.d42.s4.e0" e2="HPRD50.d42.s4.e1" id="HPRD50.d42.s4.p0" />
    </sentence>
    <sentence id="HPRD50.d42.s5" origId="9812988.2.8" text="In addition, coexpression of _____ but not ____ further stimulated the Bcl3-mediated enhancement of the 9-cis-RA-induced transactivations of RXR">
      <entity charOffset="29-33" id="HPRD50.d42.s5.e0" origId="6" type="pm0108797||pm0117490" />
      <entity charOffset="43-46" id="HPRD50.d42.s5.e1" origId="9" type="pm0126787" />
      <pair e1="HPRD50.d42.s5.e0" e2="HPRD50.d42.s5.e1" id="HPRD50.d42.s5.p0" />
    </sentence>
  </document>
</corpus>